Follow up of newly detected patients with pulmonary tuberculosis who interrupted treatment and have not treated repeatedly Source: Eur Respir J 2006; 28: Suppl. 50, 8s Year: 2006
Long-term lung function follow-up in patients diagnosed and treated for pulmonary tuberculosis Source: Annual Congress 2010 - Prognosis of tuberculosis Year: 2010
On questions of pulmonary tuberculosis relapses among patients completed the directly observed short-course chemotherapy Source: Eur Respir J 2005; 26: Suppl. 49, 647s Year: 2005
Efficacy of standard chemotherapy regimen in patients with newly detected sputum-positive destructive pulmonary tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 40s Year: 2003
Effectiveness of chemotherapy in newly detected patients with pulmonary tuberculosis with poly-resistance Source: Annual Congress 2010 - Tuberculosis drug resistance Year: 2010
Diaskintest at patients after successful treatment of lung tuberculosis Source: International Congress 2017 – Migrants and screening Year: 2017
The evaluation of the relapse or treatment interrupted pulmonary tuberculosis cases Source: Eur Respir J 2006; 28: Suppl. 50, 21s Year: 2006
6-month follow-up in patients with advanced upper lobe predominant heterogeneous emphysema treated with endobronchial lung sealant therapy Source: Annual Congress 2011 - Treatment beyond inhalers: endoscopic lung volume reduction Year: 2011
The staged cavernomyoplasty at the patients with the progressing destructive tuberculosis of a single lung Source: Eur Respir J 2007; 30: Suppl. 51, 421s Year: 2007
Directly observed therapy versus self administered therapy for patients of new smear positive pulmonary tuberculosis during hospitalisation period Source: Eur Respir J 2004; 24: Suppl. 48, 723s Year: 2004
One year follow-up of T-SPOT. TB results in treated patients with active tuberculosis Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease Year: 2007
The effectiveness of plasmaferesis in patients with relapsing and progressing course of pulmonary sarcoidosis (5 years follow-up) Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010
A randomized study of the bronchoscopic valve blockade of the affected part of the lung in the complex treatment of patients with cavitary drug-resistant pulmonary tuberculosis with treatment failure Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II Year: 2013
Treatment effectiveness among newly diagnosed patients with expanded pulmonary tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 367s Year: 2002
Safety of Mepolizumab for severe eosinophilic refractory asthma in a single-center cohort including a patient with echinococcus hepatic cyst and a patient with lung cancer . A single center one year follow up. Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019
A randomized study of bronchoscopic blockade of the affected part of a lung as a part the complex treatment of patients with drug-resistant pulmonary tuberculosis Source: Annual Congress 2012 - Tuberculosis: invasive diagnostic and therapeutic interventions Year: 2012
Evaluation of outpatient infections in lung cancer patients treated with chemotherapy and/or radiotherapy Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012
Follow up of surgically treated non small cell lung cancer patients: which modalities? Source: Annual Congress 2008 - Impact of patient education on cost-effectiveness of treatment Year: 2008
Collapso-surgical treatment of patients with diffused destructive tuberculosis of the lungs Source: Eur Respir J 2002; 20: Suppl. 38, 343s Year: 2002
Clinical course of asymptomatic small enhancing brain nodules in patients with nonsmall cell lung cancer: do we have to follow them up? Source: ERJ Open Res, 6 (3) 00109-2020; 10.1183/23120541.00109-2020 Year: 2020